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Imbalances in the formation and clearance of reactive oxygen species (ROS) can lead to oxidative stress and subsequent changes
thataﬀectallaspectsofphysiology.TolimitandrepairthedamagegeneratedbyROS,cellshavedevelopedamultitudeofresponses.
A hallmark of these responses is the activation of signaling pathways that modulate the function of downstream targets in diﬀerent
cellular locations. To this end, critical steps of the stress response that occur in the nucleus and cytoplasm have to be coordinated,
which makes the proper communication between both compartments mandatory. Here, we discuss the interdependence of ROS-
mediatedsignalingandthetransportofmacromoleculesacrossthenuclearenvelope.Wehighlightexamplesofoxidant-dependent
nuclear traﬃcking and describe the impact of oxidative stress on the transport apparatus. Our paper concludes by proposing a
cellular circuit of ROS-induced signaling, nuclear transport and repair.
1.Introduction
1.1. Reactive Oxygen Species. Oxidative stress is generated
by an increase in reactive oxygen species (ROS), either in
the form of free radicals or nonradical oxidants [1, 2].
Although elevated levels of ROS can damage a wide variety
of molecules, ROS production is essential to normal cell
physiology [3–12]. As such, ROS participate in cell-signaling
events and can function as second messengers. Moreover,
ROS are generated at sites of inﬂammation, where they fend
oﬀ microbial infections [13–16]. On the other hand, ROS are
believed to contribute to aging [3–9, 12]; they are also pro-
duced in response to environmental insults, such as X-rays,
UVlight,ultrasound,ormicrowaveradiation[17–19].Atthe
cellular level, ROS are generated as metabolic byproducts of
normal biological processes, with oxidative phosphorylation
in mitochondria as the primary source in eukaryotic cells
[20]. Aside from the mitochondrial electron transport chain,
NADPH oxidases, cyclooxygenases, lipoxygenases, xanthine
oxidase, and other cellular enzymes make also important
contributions to cellular ROS production [21–25].
The diﬀerent types of ROS and their mode of action
have been discussed in detail [1, 11, 26–30]. ROS that
are particularly important to cell physiology include the
hydroxyl radical •OH, superoxide anion •O2
−, the nonrad-
ical hydrogen peroxide (H2O2), alkoxy and peroxy radicals,
hypochlorous acid or peroxynitrite, and reactive sulfur
species [1, 29, 31, 32]. Here, we recapitulate the properties of
thoseROSonlythatarerelevanttotheexperimentsdiscussed
in this review.
The hydroxyl radical •OH is highly reactive and causes
damage to nucleic acids and proteins, this radical also
promotes lipid peroxidation [2, 12, 33]. Due to their high
reactivity, hydroxyl radicals are especially harmful and con-
sidered a major cause of oxidant-induced damage [34]. The
superoxide free radical •O2
− can interfere with the proper
function of enzymes by damaging their active sites, with
cysteine residues being particularly susceptible [32]. In an
experimentalsetting,superoxideradicalscanbegeneratedby
providing xanthine oxidase with the appropriate substrates
[35].
T h e r ei ss o m ed e b a t ea b o u tt h ei m p a c to fH 2O2 on
the cellular redox homeostasis. On one hand, H2O2 is not
deemed a major direct threat for the cellular redox homeo-
stasis due to its poor reactivity towards biomolecules [36].
However, H2O2 rapidly translocates through lipid bilayers2 Journal of Signal Transduction
and is a potential precursor for •OH radicals [32, 37]. Thus,
high concentrations of H2O2 can release iron from heme
proteins and catalyze the conversion of H2O2 to hydroxyl
radicals [37]. It was also proposed that the nonradical
oxidant H2O2 may have profound eﬀects on redox signaling
in living cells, where it alters the function of redox circuits
that are composed of redox-sensitive building blocks [1].
Despite these diﬀerent views on how H2O2 contributes
to oxidant-induced damage, we and others [38–42]h a v e
used this compound extensively to examine the impact of
oxidative stress on nuclear transport (see below).
1.2. Oxidative Stress and Cellular Defense Mechanisms. The
appropriate response to stress is fundamental to cell survival
and the recovery from disease-related or environmental
damage [3, 5, 6, 9, 11] .T h u s ,i no r d e rt om a i n t a i nr e d o x
homeostasis, the balance between production and clearance
of ROS is essential. Imbalances in ROS concentration, if
left without proper intervention, can interfere with a wide
variety of cellular processes, leading to serious injuries and
possibly cell death, either by apoptosis or necrosis [28, 43].
Upon accumulation, ROS can interact inappropriately
with a large number of biomolecules, including lipids, pro-
teins, and DNA, thereby interfering with numerous cellular
functions [28, 37]. For instance, ROS may induce damage
to various enzymes, leading to the partial or complete loss
of their function. Notably, ROS-damaged proteins can form
toxic aggregates that cause cell injury and ultimately cell
death [16]. Furthermore, ROS-induced lipid peroxidation
mayalterthepermeabilityofcellularmembranes,potentially
destroying the membrane integrity and triggering cell death
[33, 44]. In addition, ROS-induced modiﬁcations of DNA
can be mutagenic, possibly initiating cell transformation and
promoting cancer [45].
In line with the complex pattern of damage triggered
by oxidative stress, ROS accumulation contributes to the
pathophysiologies of many human diseases and syndromes.
In particular, oxidative stress plays a critical role in the onset
andtheprogressionofneurodegenerativedisorders,diabetes,
cardiovascular diseases, and nephropathy [27, 46–58].
To counteract the potential damage of elevated ROS
concentrations, cells have developed diﬀerent strategies that
limit the action of reactive compounds and prevent their
accumulation. To this end, eukaryotic cells are equipped
with multiple defense mechanisms that promote the removal
and inactivation of ROS in diﬀerent cellular compartments
[59–62]. These mechanisms rely on the coordinated action
of several enzymatic systems that are able to react with
and neutralize diﬀerent ROS. For example, the superoxide
dismutase (SOD) system is essential to redox homeostasis
[11, 63–65], as it catalyzes the conversion of •O2
− to H2O2.
H2O2 produced by SOD can then be eliminated by the
enzymatic action of catalases.
The glutathione/glutathione disulﬁde system (GSH/
GSSG) is one of the major contributors to redox homeostasis
and of particular importance to the intracellular redox
state. Accordingly, glutathione is believed to be the primary
defense when cells are injured by oxidative stress during
ischemia/reperfusion [66, 67]. Moreover, changes in the
GSH/GSSG ratio aﬀect the intracellular redox state, and
depletion of intracellular glutathione generates oxidative
stress [61]. Owing to its pivotal importance to redox
homeostasis, imbalance of the GSH/GSSG system has been
linked to many human diseases, pathologies, and aging
[11, 66, 68]. The GSH/GSSG system can be modulated
experimentally, and diethyl maleate is one of compounds
that deplete glutathione, thereby causing oxidative stress [38,
69]. Furthermore, the cellular redox homeostasis can also be
altered by changing the activity of glutathione peroxidase,
glutathione, or thioredoxin reductase.
2. OxidativeStress and
Nucleocytoplasmic Transport
2.1. Nuclear Transport of Macromolecules. Nucleocytoplas-
mic transport is central to the cellular homeostasis, as the
proper and timely response to endogenous and environ-
mental stimuli relies on the communication between the
nucleus and cytoplasm. This applies in particular to kinases
and phosphatases, many of which move in and out of
the nucleus in response to oxidants or other stressors (see
below). The nuclear envelope provides the barrier between
these two compartments [70, 71], and macromolecules
traverse the nuclear envelope via nuclear pore complexes
(NPCs). Traﬃcking in and out of the nucleus controls signal
transduction, gene expression, cell-cycle progression, and
apoptosis; regulated nuclear transport is also essential for
development and required for the proper response to stress
[72–75]. The separation of nucleus and cytoplasm is ideal
to divide signaling and other events. However, this compart-
mentalization can impede the intracellular communication
ifcomponentsofthenucleartransportapparatusareaﬀected
by ROS. This is indeed the case, as nuclear transport factors
are primary cellular targets for oxidants. Before describing
theimpact ofoxidative stressonnucleartransport, webrieﬂy
summarize those mechanisms of nuclear traﬃcking that are
relevant to our review (Figure 1).
Although diﬀusion across the NPC is not simply a
function of the molecular mass, most proteins that are
larger than 40kD do not eﬃciently diﬀuse across the nuclear
envelope. Nevertheless, molecules exceeding the diﬀusion
channel of the NPC can move in or out of the nucleus if
they carry specialized transport signals. Nuclear localization
(NLS), nuclear export (NES), or shuttling sequences serve
as permanent signals that mediate targeting to the proper
location. Classical NLSs are characterized by clusters of basic
amino acid residues, whereas NESs are frequently enriched
for leucine or isoleucine residues. However, the ﬁnal destina-
tion of a macromolecule not only depends on such transport
signals; the steady-state distribution is also controlled by its
retention in the nuclear or cytoplasmic compartment.
Nuclear Carriers. Nuclear transport of most proteins de-
pends on transporters of the importin-β group (also called
karyopherin-β). Importin-β family members interact with
their cargo either directly or through an adaptor. The latterJournal of Signal Transduction 3
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Figure 1: Simpliﬁed model for classical nuclear import and Crm1-
mediatedexport,twoessentialtransportpathways.Classicalnuclear
import depends on the carrier importin-β and the adaptor protein
importin-α. Together, importin-α/β move NLS-containing cargos
to the nucleus. The absence of RanGTP from the cytoplasm permits
the assembly of import complexes in the cytoplasm. Conversely,
the high RanGTP concentration in the nucleus promotes the
dissociation of classical import complexes after they translocate
acrosstheNPC.RanGTPinthenucleusisalsonecessarytogenerate
export complexes that contain Crm1 and NES-containing cargo.
The function of Crm1 is inhibited by leptomycin B (LMB).
applies to classical nuclear import, which relies on the
carrier importin-β1 and its adaptor importin-α (Figure 1).
Multiple isoforms of importin-α exist in higher eukary-
otes, where they recognize classical NLSs in endogenous
and ﬂuorescent cargos such as NLS-mCherry (Figure 2(a)).
Crm1/exportin-1 [76], another importin-β family member,
moves NES-containing proteins like mCit-NES to the cyto-
plasm (Figure 2(b)). This transport route can be inhibited
speciﬁcally with leptomycin B, a compound that covalently
modiﬁes a cysteine residue of Crm1 [77].
The RanGTPase System. Carriers of the importin-β family
require the small GTPase Ran and factors that mod-
ulate Ran activity. These factors include in the cyto-
plasm RanBP1 (Ran-binding protein 1) and the GTPase
activating protein RanGAP1, with RanGAP1 binding to
Nup358 at the cytoplasmic side of the NPC. By contrast,
the RanGTP-binding protein RanBP3 and the guanine
nucleotide exchange factor RCC1 (RanGEF) are located in
the nucleus, where RCC1 binds to chromatin. The asym-
metric distribution of Ran modulators generates a gradient
across the nuclear envelope, with RanGTP in nuclei and
RanGDP in the cytoplasm (Figure 1). This gradient provides
the driving force for all importin-β dependent transport
[70, 71].
Regulation of Nuclear Transport. Control of nuclear traﬃck-
ing is crucial under normal, stress, and disease conditions,
and it occurs on multiple levels [72, 73]. For instance,
phosphorylation and other posttranslational modiﬁcations
can change the transport of individual cargos [73, 78].
A more general regulation that aﬀects multiple transport
cargos is achieved by targeting components of the nuclear
transport machinery. This can be accomplished by altering
the localization or posttranslational modiﬁcation of trans-
port factors, and such changes are observed in response to
oxidative stress [72].
The following sections summarize the eﬀects of oxidative
stress on speciﬁc cargos that are relevant to human health,
the nucleocytoplasmic transport apparatus, and important
signaling components. We will then build on this informa-
tion to propose that the interdependence of oxidative stress,
nucleocytoplasmictransport,andsignalingprovidesacircuit
that controls cell survival.
2.2. Oxidative Stress Impinges on Multiple Nuclear Cargos.
As discussed above, oxidative stress causes the modiﬁcation
of targets in the nucleus and cytoplasm. Together, ROS-
dependent modiﬁcations of cargos and the nuclear transport
apparatus regulate the intracellular distribution of many
of these targets. Among the oxidant-sensitive targets that
translocate through NPCs are transcription factors, some of
which are also implicated in the stress response. Prominent
examples of transcription factors that relocate in response
to oxidative stress are NF-κB and Nrf2 (NF-E2-related
factor 2). The ROS-mediated redistribution of NF-κBa n d
Nrf2 has been described extensively [80–83] and the relevant
data will only be summarized here. Our discussion will
focus on high-mobility group box 1 protein (HMGB1) and
glycerolaldehyde-3-phosphate dehydrogenase (GAPDH) to
illustrate the link between ROS, nuclear traﬃcking and
signalling.
The role of NF-κB in immunity and inﬂammation is
well established; however, this transcription factor is also
critical for the synthesis of antioxidant proteins [80, 81]. The
genes upregulated by NF-κB include MnSOD, Cu,ZnSOD,
and HO-1 (heme oxygenase 1), all of which participate in
antioxidant defense processes. ROS and numerous other
stimuli control the intracellular distribution of NF-κB. In the
absence of these stimuli, NF-κB is retained in the cytoplasm
due to its association with I-κB. ROS trigger the degradation
of I-κB, thereby promoting the nuclear accumulation of NF-
κB and the subsequent transcription of genes that contain
NF-κB response elements [81].
Nrf2 is another key player in the antioxidant response
that relocates upon oxidant exposure. Under nonstress
conditions, concentrations of the transcription factor Nrf2
are low, and the protein is retained in the cytoplasm owing to
its association with Keap1 [82, 83]. In response to oxidative
stress, a complex series of events leads to the stabilization of
Nrf2 and its translocation into the nucleus. In the nucleus,
Nrf2 upregulates the expression of several genes that are
implicated in the antioxidant response [84]. The oxidant-
induced nuclear accumulation of Nrf2 can be mediated by4 Journal of Signal Transduction
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Figure 2: Oxidative stress inhibits classical nuclear import and
Crm1-mediated export. (a) Nuclear import. HeLa cells transiently
synthesizing the import substrates NLS-mCherry or GFP-tagged
glucocorticoid receptor (GR-GFP) were incubated under nonstress
conditions (control) or with DEM as described [69]. Note that
a signiﬁcant amount of the reporter proteins relocated to the
cytoplasm upon oxidant treatment, indicating that classical nuclear
import was inhibited. (b) Nuclear export. HeLa cells synthesizing
the ﬂuorescent reporter protein mCit-NES, a Crm1 cargo, were
exposed to DEM and processed as in part a. The Crm1 export
cargo was excluded from the nucleus under control conditions, but
relocated to nuclei upon oxidative stress. Size bar is 20μm.
importin-α5/importin-β1[ 85], whereas Nrf2 nuclear export
is promoted by Crm1 [86]. Phosphorylation of Nrf2 likely
plays a role in its nuclear import and export, with PI3 kinase
possibly stimulating Nrf2 nuclear accumulation [83, 84].
More recent studies identiﬁed HMGB1 and GAPDH
as redox sensitive proteins whose nucleocytoplasmic distri-
bution is regulated by ROS and signaling [87, 88]. Like
Keap1/Nrf2, HMGB1 functions as a redox sensor [87]. In
nuclei, HMGB1 serves as a DNA chaperone and partici-
pates in replication, transcription, as well as DNA repair.
However, HMGB1 also contributes to a variety of signaling
processes, which involve HMGB1 export to the cytoplasm
anditssubsequentsecretion.Atsteady-stateHMGB1shuttles
between the nucleus and cytoplasm, but hyperacetylation
triggers its relocation to the cytosol [89]. It was speculated
thatlysineacetylationreducesthenumberofpositivecharges
and thus interferes with nuclear import of the protein
[89]. Karyopherin-α1, a member of the importin-α family,
was identiﬁed as a binding partner that supports in vitro
nuclear import of HMGB1, most likely in conjunction
with importin-β1[ 90]. The interaction of HMGB1 with
karyopherin-α1 can be abrogated by phosphorylation, and
modiﬁcation of two NLS segments is necessary to relocate
HMGB1 to the cytoplasm [90]. Taken together, a combina-
tion of acetylation and phosphorylation controls HMBG1
nuclearaccumulation. Theseposttranslational modiﬁcations
likely prevent the recognition of HMBG1 by the classical
import apparatus.
Nuclear export of HMGB1 is at least in part mediated
by Crm1, as leptomycin B drastically reduced HMGB1 exit
from the nucleus [89]. Treatment with H2O2 upregulated
the interaction Crm1/HMBG1 and relocated HMBG1 to
the cytoplasm for secretion [91]. This oxidant-dependent
secretion was sensitive to JNK and MEK inhibitors, in line
with the idea that several members of the MAP kinase
families control HMBG1 movement from the nucleus to the
cytoplasmanditssubsequentrelease.Inotherstudies,IL-1β-
dependent ERK1/2 activation increased the concentration of
Crm1 and led to HMBG1 accumulation in the cytoplasm
[92]. Whether H2O2 treatment, which activates ERK1/2, has
the same eﬀect on Crm1 levels is an exciting question that
has to be answered in the future.
In recent years GAPDH has emerged as an enzyme that is
involved in diverse cellular processes [88, 93]. Thus, GAPDH
not only functions in glycolysis in the cytoplasm, but also
plays additional important roles in other compartments of
the cell, including the nucleus [88, 94–101]. The nuclear
accumulation of GAPDH is controlled by posttranslational
modiﬁcations and the interaction with diﬀerent binding
partners in the cytoplasm and nucleus. In response to
oxidative stress, GAPDH undergoes S-nitrosylation and
subsequent association with Siah. The GAPDH-Siah com-
plex then moves into the nucleus, where it participates
in the regulation of gene expression and apoptosis [88].
GAPDH nuclear accumulation depends on the acetylation
of three lysine residues by the acetyltransferase p300 [101].
Furthermore, O-GlcNAc glycosylation of GAPDH occurs
close to the Siah-binding site, and this modiﬁcation pro-
motes GAPDH nuclear accumulation [100]. Although notJournal of Signal Transduction 5
tested by the authors, O-GlcNAc modiﬁcations rise in
response to oxidative stress [102] and could therefore assist
in the stress-induced nuclear accumulation of GAPDH.
Interestingly, the nucleocytoplasmic traﬃcking of GAPDH
has been linked to several signaling pathways. In particular,
activation of AMPK promoted the nuclear accumulation of
GAPDH, whereas signaling through the PI3 kinase→Akt
moduleisrequiredforCrm1-dependentnuclearexport[96].
The intracellular location of GAPDH is directly relevant
to human health (see below). For example, when in the
nucleus GAPDH might contribute to the initiation of
apoptosis in brain cells. Moreover, the oxidant-induced
changes in GAPDH subcellular localization probably play a
role in the pathology of Alzheimer disease [93]. GAPDH is
also critical to the development of diabetic complications,
and changes in its nuclear accumulation might aggravate
diabetic retinopathy [97].
Taken together, there is a growing list of proteins whose
nucleocytoplasmic distribution is controlled by the intra-
cellular redox homeostasis. This regulation frequently relies
on posttranslational modiﬁcations, which can alter the
interaction of a particular cargo with its carrier or the
retention in nuclear and cytoplasmic compartments.
2.3. Oxidative Stress as a Key Player in Human Health. The
cellulardamagecausedbyoxidativestresspromotestheonset
as well as progression of several diseases and pathophysiolo-
gies. Thus, oxidative stress plays a critical role in neurode-
generative disorders, cardiovascular and metabolic diseases,
as well as the complications associated with diabetes. Here,
we focus on some examples that highlight the adverse eﬀects
of oxidative stress on human health.
Oxidative Stress and Neurodegenerative Diseases. The human
brain is particularly vulnerable to oxidant-induced damage
owing to high oxygen consumption, lipids rich in polyun-
saturated fatty acids, high amounts of redox-active transi-
tion metals, and relatively poor defense against oxidative
stress [30, 48, 103]. Several lines of evidence implicate
oxidative stress in the neuronal damage that accompanies
neurodegenerative disorders [25, 30, 34, 103, 104]. For
instance, analysis of cerebrospinal ﬂuid, plasma, and urine
samples or postmortem brain specimens demonstrated the
increase in oxidative damage in patients suﬀering from
amyotrophiclateralsclerosis[105],Friedreichataxia,Parkin-
son, Alzheimer, and Huntington diseases [30, 48, 103].
Oxidant-induced injury is elevated in the brain at early
stages of these diseases, supporting the model that oxidative
stress contributes to the etiology of neurodegeneration. In
line with this hypothesis, mitochondrial dysfunction and
oxidative damage to mitochondrial proteins are shared
features of diﬀerent neurodegenerative diseases [25, 30,
34, 103]. Animal models further support this idea, as
inhibitors of mitochondrial function can induce some of
the pathologies associated with Parkinson disease [34]. In
addition, proteomics identiﬁed a large number of proteins
that show increased oxidative damage in patients suﬀering
from various forms of neurodegeneration. These proteins
include several enzymes that are critical to oxidative phos-
phorylation and glycolysis. Notably, when compared to con-
trol subjects GAPDH oxidation was increased in Alzheimer
and Parkinson patients; GAPDH was also aﬀected in ALS
mouse models [103]. This is signiﬁcant, because GAPDH
and its subcellular traﬃcking are of particular importance
to human metabolism and the pathologies associated with
neurodegenerative diseases. As such, oxidative damage not
only reduces the enzymatic activity of GAPDH in Alzheimer
disease, but also supports the association with Siah and the
subsequent translocation of the GAPDH-Siah complex to
the nucleus (see above). In Alzheimer disease, both GAPDH
expression and nitrosylation are increased, probably leading
to elevated concentrations of GAPDH-Siah in the nucleus,
which in turn promotes apoptosis [93]. Taken together, the
oxidant-induced changes in GAPDH enzyme activity and
intracellular distribution will reduce the energy supply and
advance apoptosis in the brain of Alzheimer patients. Since
GAPDH is an established target of oxidative damage in
severalneurodegenerativediseases[103],itispossiblethatits
oxidant-dependent change in nuclear transport and the sub-
sequent increase in cell death are common to multiple forms
of neurodegeneration. Interestingly, GAPDH also plays a
critical role in the development of diabetic complications.
Oxidative Stress and Diabetes. Oxidative stress is crucial to
the etiology of diabetes mellitus and the ensuing damage
to diﬀerent tissues and organs [27, 49, 55, 106, 107]. Thus,
oxidativestresscanalterinsulinsignalingbytargetinginsulin
receptor and insulin receptor substrates or through the
activation of ser/thr kinases that regulate insulin signaling
[55].Inthisscenario,theROS-inducedchangestotheinsulin
signaling pathway will advance insulin resistance and the
subsequent development of diabetes. PI3 kinase and the
MAP kinases ERK1/2 are major components of insulin-
mediated signaling. Interestingly, signaling through these
kinases is also modulated by oxidative stress and regulates
nuclear traﬃcking (see below).
Oxidative stress not only promotes the development of
diabetes, but diabetes also triggers the increase in oxidative
stress due to elevated blood glucose and free fatty acids.
Such disease-induced ROS production further exacerbates
cellular damage and contributes to diabetic complications.
In the following, we discuss some of the routes that generate
oxidative stress in the diabetic patient [49, 55, 106–108].
Hyperglycemia rises intracellular glucose concentrations
and the subsequent production of pyruvate, which is
ultimately metabolized via the tricarboxylic acid cycle. As
a result of the high abundance of pyruvate, increased
amounts of NADH and FADH2 are generated by the
tricarboxylic acid cycle. Both NADH and FADH2 enter
into the mitochondrial electron transport chain, but their
excess interferes eventually with the proper transfer of
electrons. As a consequence of this overload, superoxide
production by mitochondria increases and promotes cellular
damage, especially in the diabetic vasculature [109, 110].
The importance of mitochondria in hyperglycemia-induced
injuries was demonstrated experimentally, as inhibitors of6 Journal of Signal Transduction
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Figure 3: Oxidative stress interferes with importin-α1-dependent
import of endogenous cargos. The import of two endogenous
proteins, the RNA-binding protein HuR and galectin-3, was moni-
tored in HeLa cells under the conditions described for Figure 2(a).
Importin-α1 promotes nuclear import of both proteins. HuR and
galectin-3 were visualized by indirect immunoﬂuorescence and
nuclei were stained with DAPI [69]. HuR was nuclear in control
cells and redistributed to the cytoplasm of stressed cells, where
it accumulated in stress granules (SGs). Similarly, galectin-3 was
more concentrated in the nuclei of control cells and relocated to
the cytoplasm upon DEM treatment. Arrows indicate the position
of some of the SGs.
the electron transport chain, upregulation of the uncoupling
protein UCP1, or mitochondrial SOD ameliorated some of
the damage [49, 106].
The excess of mitochondrial superoxide, combined
with other hyperglycemia-induced changes, culminates in
secondary diabetic complications. In particular, diabetic
nephropathy, retinopathy, neuropathy, and cardiomyopathy
arisefromthemodulationofmultiplebiochemicalpathways,
some of which alter the cellular redox homeostasis [27,
49, 107]. For example, upon diabetes, the abundance of
intracellular glucose and glycolytic metabolites leads to the
increased production of sorbitol and other sugar alcohols
by the polyol pathway. This generation of sugar alcohols
mediatedbymembersofthealdo-ketoreductasefamilyrelies
on the conversion of NADPH to NADP+ [49]. Since NADPH
is necessary to generate GSH from GSSG, excessive NADPH
consumption will compromise the antioxidant defense and
promote ROS-induced damage.
Moreover, ROS concentrations can also be elevated by
hyperglycemia-dependent changes in cell signaling. As de-
scribed above, GAPDH is sensitive to oxidative stress, and
the inhibition of GAPDH by ROS increases intracellular
concentrations of triose phosphate, a precursor of the
PKC activator diacylglycerol. Hence, hyperglycemia triggers
PKC activation, thereby changing the signaling events in
the diabetic retina, heart, and endothelial cells [49, 106].
Moreover, this hyperglycemia-induced PKC activation is
particularly detrimental to the kidney, as it stimulates ROS
production by NAD(P)H oxidases and advances diabetic
nephropathy [106, 111].
Likeotherformsofstress,diabetesmodulatesthenucleo-
cytoplasmicdistributionoftranscriptionfactors,withNF-κB
as a prominent example [112]. Similarly, high glucose con-
c e n t r a t i o n sa c c u m u l a t e dG A P D Hi nt h en u c l e u so fb o v i n e
retinal endothelial cells [97], where it could contribute to the
progression of diabetic retinopathy.
Thedownstreameﬀectsofhyperglycemiafurtherinclude
changes in the posttranslational modiﬁcation of proteins.
Thus, elevated glucose concentrations raise the amount of
fructose-6-phosphate that enters the hexosamine pathway
[27, 106], which in turn increases the production of UDP-
N-Acetylglucosamine and the subsequent O-GlcNAc modi-
ﬁcation of proteins. These changes are important to nuclear
transport, because nucleoporins are well established targets
for O-GlcNAc-glycosylation.
In summary, oxidative stress is implicated in diﬀerent
pathophysiological conditions, some of which alter the
proper coordination of nuclear and cytoplasmic events. As
discussed in the following section, ROS impinge on the
nucleartransportapparatusandtherebymodifythecommu-
nication between nucleus and cytoplasm.
2.4. Nuclear Transport and Redox Homeostasis. Changes in
cell physiology aﬀect nucleocytoplasmic traﬃcking in a wide
variety of eukaryotes, and the eﬀects of oxidative stress on
the nuclear transport apparatus have been analyzed during
the past years. We have shown for the yeast S. cerevisiae
and mammalian culture cells that diﬀerent forms of stress,
including oxidants, heat, and nutrient deprivation inhibit
classical nuclear import and export [38, 39, 69, 72, 79, 113–
121]. Our previous studies examined the impact of severe
and mild oxidative stress. While severe oxidative stress was
produced with high concentrations of H2O2 [39], mild
oxidative stress was generated by the oxidant diethyl maleate,
DEM [69]. Under severe stress conditions, cells underwent
apoptosis, but a large fraction of cells survived the milder
stress inﬂicted with DEM [69]. Nevertheless, Figures 2 and
3 show that DEM treatment diminished nuclear transport
of both ﬂuorescent reporter proteins and endogenous cargos
[69, 79, 117]. This is not simply a consequence of stress-
induced permeabilization of nuclear envelopes, because the
barrier function of nuclear membranes was preserved underJournal of Signal Transduction 7
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Figure 4: Mild and severe oxidative stress have diﬀerent eﬀects on nuclear transport factors. The eﬀects of mild (2mM DEM) and severe
oxidative stress (10mMH2O2) on the subcellular distribution of importin-α1, Ran, and HuR were analyzed in HeLa cells. Proteins were
located by indirect immunoﬂuorescence [39, 69, 79]. DEM treatment accumulated importin-α1 in nuclei but did not drastically aﬀect the
distribution of Ran. By contrast, severe oxidative stress induced by H2O2 caused a pronounced nuclear accumulation of importin-α1a n d
collapsed the nucleocytoplasmic Ran gradient. Both treatments relocated HuR to the cytoplasm. However, DEM triggered the assembly of
HuR-containing SGs, which were rare or absent upon incubation with H2O2.
these conditions [122]. Since ﬂuorescent reporter proteins
like NLS-mCherry or mCit-NES do not contain nuclear or
cytoplasmic retention signals, it was reasonable to assume
that their stress-induced redistribution reﬂected changes to
the transport apparatus. As described below, such changes
were indeed reported by diﬀerent laboratories, both for
severe and mild forms of oxidative stress.
A common consequence of H2O2-induced severe oxida-
tive stress is the collapse of the nucleocytoplasmic Ran
GTPase gradient in growing cells (Figure 4); this collapse
contributes to classical import inhibition [35, 38, 39, 121].
In addition, three key components of the transport appa-
ratus, nucleoporin Nup153, the carrier importin-β1, and
importin-α1(Figure 4),redistributedwhencellsweretreated
with H2O2 [39]. Aside from transport factor redistribution,
H2O2 also caused the degradation of Ran, Nup153 and
importin-β1, both by proteasome and caspase-dependent
mechanisms. In addition to growing cells, the consequences
of H2O2 incubation were also examined in vitro. In these
experiments, oxidant treatment led to a signiﬁcant reduction
of the docking step of nuclear import, as it diminished the
binding of importin-α1/β1/cargo complexes at the nuclear
envelope [39].
Our more recent studies investigated how nonlethal
oxidative stress aﬀects the transport apparatus. To this
end, intracellular glutathione concentrations were depleted
with DEM. Unlike severe oxidative stress, DEM incubation
caused neither a dissipation of the Ran gradient (Figure 4)
nor the degradation of transport receptors. However,
DEM treatment mislocalized several transport components,
including importin-α1, its nuclear exporter CAS as well
as nucleoporins Nup153, Nup88, and Nup50 [69]. Nuclear
retention was one of the mechanisms that contributed to
the oxidant-induced nuclear accumulation of these proteins.
Concomitant with nuclear retention, high molecular mass
complexes were formed in nuclei that contained importin-
α1, Nup153, and Nup88. A second mechanism promoting
the redistribution of transport factors was the increase in
nuclear import for importin-α1 and CAS [69]. Notably,
the subcellular redistribution of importin-α1, CAS, Nup153,
and Nup88 was accompanied by changes in their posttrans-
lational modiﬁcation. For example, DEM augmented the
phosphorylation for each factor and increased the O-GlcNAc
modiﬁcation of Nup153 [117]. All of these events are pos-
sibly linked to oxidant-induced signaling, as the relocation
of importin-α1, CAS, Nup153 and Nup88 was modulated by
MEK→ERK1/2 and PI3K→Akt pathways [117].
Oxidative stress not only inhibits nuclear import, the
Crm1 export pathway is sensitive to oxidants as well [79],
and our group demonstrated that Crm1-mediated export
was inhibited by DEM. Consequently, mCit-NES, a Crm1
cargo predominantly in the cytoplasm of unstressed cells,
relocated to nuclei in DEM-treated samples (Figure 2).
Several mechanisms participated in the oxidant-induced
inhibition of Crm1-dependent export [79]. First, oxidative
stress changed the association of Nup358, Nup214, Nup62,
and Crm1 with the nuclear envelope and redistributed
Nup98. Second, the interaction among these nucleoporins
was altered. Third, oxidant treatment impaired Crm1 exit
from the nucleus and increased its binding to Ran.
Takentogether,thesestudiesrevealedthatoxidativestress
alters several steps of classical nuclear import and export8 Journal of Signal Transduction
and substantiated the hypothesis that the nuclear transport
apparatus is an important target for oxidants. Some of
the oxidant-sensitive components are shared by import and
export pathways, which might explain why both transport
routes are aﬀected in stressed cells.
Work by other groups identiﬁed additional transport
factors that are likely controlled by ROS homeostasis [72].
For instance, ceramide inhibited nuclear import through a
pathway that relied on the MAPK p38 [123]. As ceramide
is believed to cause oxidative stress [124, 125], these exper-
iments provide another link between ROS imbalance and
changes in nuclear traﬃcking. This idea is further supported
by experiments in smooth muscle cells, where lysophos-
phatidylcholine modulated RanGAP1 activity [126]. Since
lysophosphatidylcholine can induce ROS production [127],
RanGAP1 and thereby the generation of RanGDP in the
cytoplasm are potential candidates for ROS-dependent regu-
lation. The role of RanGAP1 as an oxidant-sensitive target in
the cytoplasm is signiﬁcant, because RanGAP1 promotes the
termination of protein export for all importin-β like carriers.
Furthermore, RanGAP1 has emerged as target for several
MAP kinases [128], emphasizing its potential to serve as a
redox-sensitive transport regulator at the NPC.
The idea of redox-dependent control at the nuclear pore
is consistent with a recent publication that detected the MAP
kinases ERK, p38, and JNK at the NPC [129]. Importantly,
all of these kinases are activated and/or redistributed by
ROS (Table 1). Moreover Nup50, Nup153, and Nup214
are established ERK targets [130], and their phosphory-
lation changed several interactions that are important for
nuclear transport. Speciﬁcally, ERK-dependent modiﬁcation
of Nup50 interfered with its binding to importin-β and
transportin,whicharebothcarriersoftheimportin-βfamily.
Similarly, when Nup153 and Nup214 were phosphorylated
by ERK, their association with importin-β was reduced.
In summary, multiple signaling pathways are activated
by oxidants, MAP kinases reside at the NPC or relocate
upon stress (see below), and several transport factors are
targeted by these kinases. Hence, it is reasonable to propose
a simpliﬁed chain of events: oxidative stress → signaling →
transport factor modiﬁcation and/or relocation → changes
in nuclear traﬃcking → altered distribution of cargos. This
is by no means a one-way street, as nuclear transport factors
also play a critical role in modifying signaling events.
An example for the interdependence of signaling and
nuclear transport is provided by RanBP3. This transport
factor is not only regulated by multiple kinase modules,
it also controls signaling [131, 132]. RanBP3 is predom-
inantly located in the nucleus and a binding partner for
Ran, RCC1, and Crm1. Aside from participating in Ran
translocation to the cytoplasm, RanBP3 may also sequester
Ran in the nucleus [131]. Phosphorylation by RSK and
Akt can modulate RanBP3 function. In particular, RanBP3
modiﬁcation is believed to stimulate nuclear import by
regulating its interaction with RCC1. In support of this
model, nonphosphorylatable mutants of RanBP3 displayed
a reduced ability to stimulate RCC1 in vitro and caused
a partial dissipation of the Ran gradient in growing cells
[131]. The emerging scenario is that signaling through
Ras → MEK1/2 → ERK1/2 → RSK and PI3 kinase → Akt
leads to RanBP3 phosphorylation, thereby maintaining the
Ran gradient. Since both signaling pathways are modulated
by ROS, it is tempting to speculate that their activation by
oxidantswillhelptopreserveorre-establishtheRangradient
in stressed cells.
Besides being a downstream target of several signaling
pathways, RanBP3 has a critical role in controlling TGF-β
signaling [132]. Signaling through TGF-β and its receptors
have multiple links to oxidative stress [133–136], and many
eﬀects of TGF-β-like ligands are exerted by the downstream
transcriptional regulators Smad2/3. Smad2/3 are shuttling
proteins, and their transport to the nucleus relies on direct
binding to importin-β, without involvement of the adaptor
importin-α [137]. Following activation of TGF-β,S m a d 2 / 3
are phosphorylated and accumulate in nuclei, where they
regulate the expression of target genes. The termination of
TGF-β signaling involves the dephosphorylation of Smad2/3
and their export to the cytoplasm. Notably, Smad2/3 nuclear
export is not sensitive to leptomycin B, suggesting that Crm1
isnotrequiredforexitfromthenucleus.Indeed,RanBP3was
identiﬁed as a possible carrier that helps to move Smad2/3 to
the cytoplasm [132]. Several lines of evidence support this
idea; RanBP3 bound nonphosphorylated Smad2/3, inter-
acted with Smad2/3 in the nucleus and promoted Smad2/3
nuclear export in a Ran-dependent fashion. Together, these
studies established an essential role for RanBP3 as a negative
regulator of Smad2/3 signaling, which relies on its ability to
transport Smad2/3 to the cytoplasm.
The impact of ROS on nuclear transport is not limited
to signaling-dependent eﬀects, since ROS can directly induce
the modiﬁcation of nuclear transport components. Protein
carbonylation is one of the consequences of oxidative stress,
and it occurs in an age-dependent fashion for nucleoporins
Nup153 and Nup93. Nucleoporin carbonylation correlated
withthe“leakiness”ofNPCs[138],andcouldbeparticularly
harmful to postmitotic cells, in which some nucleoporins
are replaced only slowly. In the context of signaling, it
will be interesting to determine whether the age-dependent
nucleoporin carbonylation alters the NPC association of
MAP kinases or nucleoporin phosphorylation.
In summary, experiments described above suggest that
the stress-induced modulation of nuclear traﬃcking is
caused by changes in the concentration, distribution, and
posttranslational modiﬁcation of transport factors [72, 82].
This process is further complicated by the fact that oxidant-
dependent relocation of transport factors can be compart-
mentalized even within the nucleus or cytoplasm, as shown
by the formation of cytoplasmic stress granules.
2.5. Oxidative Stress, Stress Granule Assembly, and Nuclear
Transport. One of the possible consequences of oxidative
stress is the formation of cytoplasmic stress granules (SGs).
SGs are generated in response to stress that leads to the accu-
mulation of stalled translation initiation complexes [139,
140]. SG assembly is part of a stress defense mechanism that
helps to retain and protect mRNAs from degradation. One
of the signaling events crucial for the formation of most SGsJournal of Signal Transduction 9
Table 1:Redox-sensitivecellulartargetsineukaryoticcells.Componentsthataltertheiractivityand/ornucleocytoplasmicdistributionwhen
ROS concentrations increase are listed. See text for details.
Component or process Eﬀect of ROS
Signaling proteins, transcriptional regulators
JNK, MAPK Activation
p38, MAPK Activation, nuclear translocation
ERK1/2, MAPK Activation, nuclear accumulation
PI3 kinase (some isoforms) Activation, changes in nucleocytoplasmic distribution
5 -AMP activated kinase Inhibition, nuclear accumulation; possibly by reduced nuclear export
via Crm1
Human insulin receptor kinase activity Activation
Src family kinases Activation
EGFR Nuclear translocation; DNA repair
Protein tyrosine phosphatases Inactivation
PTEN Nuclear accumulation; association with p53
STAT3 Nuclear translocation
NF-κB, transcription factor Nuclear accumulation; transcription
FoxO transcription factors Nuclear translocation (i.e., FOXO1, FOXO3a, and FOXO4)
yAP-1, yeast transcription factor Nuclear translocation
Msn2p, Msn4p, yeast transcription factors Nuclear translocation, transcription
CREB Phosphorylation, nuclear translocation
Nrf2 Nuclear accumulation
HMGB1 Cytoplasmic translocation
HuR, RNA-binding protein Relocation to cytoplasm, accumulation in stress granules
Nuclear transport apparatus
Classical nuclear import Inhibition
Crm1-dependent nuclear export Inhibition
Ran, small GTPase; Gsp1 in S. cerevisiae Relocation to cytoplasm upon severe oxidative stress
Importin-α1, adaptor for classical nuclear import Accumulation in nuclei, accumulation in cytoplasmic stress granules
Crm1, nuclear exporter Accumulation at nuclear envelope
CAS, exporter for importin-α Nuclear accumulation
Multiple nucleoporins located at diﬀerent positions
within the nuclear pore complex: Nup358, Nup214,
Nup88, Nup62, Nup153, Nup50, Nup98, and others
Changes in the association with nuclear envelope; altered
nucleocytoplasmic distribution; degradation upon severe stress, in
some cases mediated by caspases.
is Ser51 phosphorylation on eIF2α (eukaryotic translation
initiation factor 2) [139–141]. Ser51 can be modiﬁed by
four diﬀerent upstream kinases, PKR, PERK, GCN2, and
HRI (heme-regulated initiation factor 2 kinase), which are
activated by various stressors, including the oxidant arsenite.
Other signaling events are relevant to SG biogenesis and dis-
assembly; for instance, arsenite promotes the sequestration
of Rho and ROCK1 in SGs, possibly to limit the activation of
the downstream target JNK [142]. Moreover, focal adhesion
kinase (FAK) controls the disassembly of SGs and can be
stimulated with H2O2 [143, 144].
In addition to components of the small ribosomal
subunit and RNA-binding proteins, arsenite-induced SGs
contain importin-α1[ 145]. Notably, importin-α1 knock-
down delays SG formation, suggesting a role in the dynamics
of SG assembly. These are important data which further
substantiate the contribution of nuclear protein transport
factors to the stress response. At present, we do not fully
understand these events; however, it is conceivable that
SGs are one of the “hubs”, where ROS-mediated signaling
and nuclear transport components come together in the
cytoplasm. Results for the mRNA-binding protein HuR
support this idea. HuR shuttles between the nucleus and
cytoplasm and relies on importin-α1 for nuclear import.
Under normal growth conditions, HuR is predominantly
in the nucleus, but a 4-hour DEM treatment concentrated
HuR in SGs (Figures 3 and 4). At the same time, importin-
α1 accumulated in nuclei, but it was still detectable in
the cytoplasm [69, 117]. It should be emphasized that the
associationofmacromoleculeswithSGsisdynamic.Proteins
as well as RNA can shuttle between SGs and the surrounding
cytoplasm [141, 146], and this may also apply to importin-
α1.
What are the possible mechanisms that promote the
ROS-dependent changes in importin-α1 and HuR distri-
bution and how are these events linked to SG assembly?10 Journal of Signal Transduction
The DEM-induced relocation of HuR is likely driven by
the combination of importin-α1 nuclear accumulation and
HuR association with SGs. In particular, concentrating
importin-α1innucleiofstressedcellscoulddiminishnuclear
import of HuR. At the same time, importin-α1h a sar o l e
in SG biogenesis. Although details of this process have
yet to be deﬁned, importin-α1 may recruit components
to cytoplasmic foci that are destined to form SGs. Given
that importin-α1 binds and transports a variety of cargos,
importin-α1 shuttling between SG foci and the cytoplasm
could accomplish this task. If our model is correct, it could
help explain the lack of SG formation in cells incubated with
H2O2 [147, 148]. As shown in Figure 4,H 2O2 did not induce
SGs, and importin-α1 became highly concentrated in the
nucleus,withlittleoftheproteinremaininginthecytoplasm.
Moreover, stress can also increase nuclear retention and
import of importin-α1[ 113]. As a result of these events, the
concentration of importin-α1 in the cytoplasm will be low
when cells are treated with H2O2, which in turn could limit
the formation of SGs.
The potential contribution of nuclear transport factors
to SG assembly or function is not restricted to importin-
α1. Support for this notion comes from importin-β family
members importin 8 and transportin which localize to
SGs upon arsenite treatment [149, 150]. At this point,
we have only few examples that connect nuclear transport
componentswithSGs,andfuturestudieswillhavetounravel
how nuclear traﬃcking, SG assembly, and ROS-dependent
signaling are integrated.
2.6. Oxidative Stress and the Subcellular Distribution of
Key Signaling Molecules. Elevated levels of ROS modify the
activity of redox sensitive components that participate in
signaling or other essential biological processes [1, 6, 9,
39, 69, 79, 87, 88, 114, 116, 151–153]. Notably, such ROS-
dependent changes in activity are frequently accompanied
by the intracellular relocation of the redox-sensitive factors.
This scenario applies to a growing list of protein kinases,
phosphatases, transcription factors, and components of the
nuclear transport apparatus (Table 1). Several of the kinases
and phosphatases that redistribute under oxidative stress
conditions are key players in signaling circuits, where they
control cell survival, growth, proliferation, or death. The
interdependence of the activation status and intracellular
distribution is crucial for these enzymes, as it determines
the speciﬁcity and duration of signaling events [152, 154–
156]. In the following, we discuss some of the kinases and
phosphatases for which oxidant-dependent relocation has
been established.
The activity and location of several members of the
MAPK and PI3 kinase families are modulated by ROS.
Suchspatiotemporalcontrolisparticularlyimportantforthe
response to stress, where the repair of stress-induced damage
and cell survival relies on the outcome of compartment-
speciﬁc signaling events. Multiple signaling modules that
respondtoROS,bothbyactivationandrelocation,havebeen
analyzed in our group [114, 116]. We focused on Akt and
ERK1/2, kinases that are essential for signal transduction
through PI3 → Akt and MEK → ERK1/2 modules. The
stressorDEMelevatedthephosphorylationofAktonThr308
and Ser473, which leads to Akt activation. At the same time,
DEM induced the dual phosphorylation of ERK1/2, thereby
activating the MAP kinases. Importantly, DEM not only
activates Akt and ERK1/2, but also increased signiﬁcantly
the nuclear/cytoplasmic ratio of phospho-Akt(Ser473) and
dually phosphorylated-ERK1/2 [114]. A possible outcome
of this shift is a change in the phosphorylation proﬁles of
nuclear and cytoplasmic targets. Notably, the compartmen-
talization of Akt and ERK1/2-dependent signaling events
is even more complex [114], as we demonstrated in the
nucleus a direct correlation between the levels of phospho-
Akt(Ser473) and phospho-ERK1/2. Our studies suggested
that the nuclear concentration of phospho-Akt(Ser473) is
dependent on nuclear phospho-ERK1/2 and vice versa.
Accordingly, crosstalk occurs between phospho-Akt(Ser473)
and ERK1/2 in response to oxidative stress; this crosstalk is
speciﬁc for the nuclear compartment.
MorerecentworkonPI3kinasebyothersfurtherempha-
sizes the importance of the localized action of signaling
molecules. The PI3 kinase catalytic subunit p110β carries a
nuclear localization signal in its C-terminal domain, while
the regulatory subunit p85β harbors a nuclear export signal.
The analysis of a p110β transport mutant showed that the
ability of the p85β/p110β complex to regulate cell survival
was strictly dependent on its nuclear localization [157].
Although the eﬀect of oxidative stress on the distribution of
this kinase has yet to be determined, these ﬁndings provide
compelling evidence for the control of cell signaling by
nuclear transport.
Another example that illustrates the ROS-dependent
activation and distribution of protein kinases is the het-
erotrimeric enzyme 5 -AMP activated kinase (AMPK).
AMPK is an energy sensor which plays a pivotal role in
the regulation of metabolic homeostasis by phosphorylating
targets that are involved in glucose, carbohydrate, lipid,
and protein metabolism [158–161]. In unstressed cells,
AMPK shuttles between the nucleus and cytoplasm and
this shuttling relies on the nuclear exporter Crm1 [116,
162]. However, in response to oxidative stress, AMPK α-
and β-subunits concentrated in the nucleus. This could be
accomplished—at least in part—by ROS-induced changes
to the nuclear export apparatus, as Crm1 is one of the
transport components that are aﬀected by ROS (see above).
Interestingly, the link between AMPK activity, subcellular
distribution, and nuclear traﬃcking is even more intricate,
as importin-α1, a component of the nuclear transport
apparatus, is also modiﬁed by AMPK [163].
E p i d e r m a lg r o w t hf a c t o rr e c e p t o r( E G F R )i sar e c e p t o r
tyrosine kinase that is especially important to human health,
because signaling through EGFR is linked to tumorige-
nesis, metastasis and radioresistance. EGFR is located in
the plasma membrane, but it also entered the nucleus in
response to oxidative stress, heat, or radiation [164]. More-
over, incubation of cultured cells with hydroxy-nonenal, a
compound generated by lipid peroxidation, promoted the
nuclear accumulation of EGFR [19]. When in the nucleus,
EGFR stimulated DNA repair, a process that contributesJournal of Signal Transduction 11
to radioresistance and potentially limits the success of
radiotherapy. Since EGFR is membrane bound, details of
its nuclear transport are likely to diﬀer from soluble cargos.
Nevertheless, importin-β1a n dC r m 1( Figure 1) were identi-
ﬁed as nuclear carriers that participate in EGFR traﬃcking
[165, 166].
The link between oxidative stress and the localization of
key signaling components is not limited to protein kinases.
For instance, the lipid and protein phosphatase PTEN has
functions in the nucleus and cytoplasm, and oxidative stress
promotes PTEN nuclear accumulation [167]. In cells treated
with H2O2, PTEN concentrated in nuclei, where it stabilizes
the tumor suppressor p53. Under normal conditions, PTEN
is exported from the nucleus by the carrier Crm1 in a
cell-cycle dependent fashion, and this export relied on
signaling through PI3 kinase [168]. However, incubation
withH2O2 inducedPTENphosphorylationonSer380,which
inhibited its nuclear export [167]. The control of PTEN
shuttling upon oxidative stress probably goes beyond the
oxidant-induced phosphorylation of the enzyme. As such,
the exporter Crm1 is one of the cellular targets that are
sensitive to ROS, and signaling through the PI3 kinase →
Akt module regulates several components of the nuclear
transport apparatus [79, 117]. This interdependence of
nuclear transport and signaling is further complicated by
the fact that the enzymatic activity of PTEN is regulated by
oxidants (see below).
For the examples discussed here, ROS-mediated changes
in the nucleocytoplasmic distribution of kinases and phos-
phatases could reﬂect the requirement to modify selected
substrates in speciﬁc subcellular compartments. To this end,
the ROS-induced nuclear accumulation of ERK1/2, PI3
kinase, AMPK, EGFR, or PTEN will alter the phosphoryla-
tion and activity of nuclear substrates such as transcription
factors and other regulators of gene expression. However,
such redistribution will also impact other compartments,
because the sequestration of kinases or phosphatases in the
nucleus can change the phosphoproteome in the cytoplasm
as well.
2.7. What Is the Interface between the Initial Oxidant Ex-
posure and Changes in the Nuclear Transport Apparatus?
As discussed in previous sections, oxidative stress targets
components of the nuclear transport machinery. Moreover,
diﬀerent signaling cascades are implicated in the control
of traﬃcking across the NPC, in part by regulating the
posttranslationalmodiﬁcationofnucleartransportfactors.A
complete mechanistic understanding of these events requires
that the initial impact of the oxidant can be connected
to functional changes of the nuclear transport apparatus.
For many of the processes described here, the interface
between the primary oxidant-induced event and changes in
the posttranslational modiﬁcation or function of transport
factors is not fully deﬁned. In the following, we will,
therefore, speculate on some of the possible links.
In principle, two distinct mechanisms can underlie the
eﬀect of ROS on nuclear transport factors. First, ROS might
react directly with the nuclear transport apparatus, leading
to the covalent modiﬁcation of individual components.
Second,oxidativestresscouldactivatesignalingcascadesthat
ultimately trigger the phosphorylation and/or O-GlcNAc
glycosylation of the transport machinery. In the second
scenario, signaling begins with a redox-sensitive target that
induces a chain of events which conclude with the post-
translational modiﬁcation of one or more nuclear transport
factors.
Direct Modiﬁcation of the Nuclear Transport Apparatus by
ROS. In line with what is known about redox-sensitive
residues in proteins, we expect that for nuclear transport
componentscysteine,methionine,lysine,arginine,andhisti-
dine residues are among the side chains that are particularly
prone to direct oxidation or other ROS-dependent modiﬁ-
cations [169]. This idea is supported by a study describing
the S-nitrosylation of Crm1 on two cysteine residues and the
concomitant inhibition of Crm1-mediated nuclear export
[170]. Besides Crm1, nucleoporins are other candidates for
a direct modiﬁcation by ROS or compounds generated upon
oxidative stress. Our hypothesis is supported by the increase
in nucleoporin carbonylation when cells encounter oxidative
stress [138].
Signaling as Possible Interface between Oxidant Exposure
and Nuclear Transport Modiﬁcation. Although many of the
enzymes that mediate the posttranslational modiﬁcation of
transport factors are known, upstream events regulating
these enzymes are less well understood. This applies in
particulartotheﬁrststepoftheprocess,thatis,theimpactof
ROS on its primary target. We propose that protein kinases,
phosphatases, or small GTPases that are redox-sensitive
[171–174] could ﬁll this gap, as they activate signaling
pathways that culminate in transport factor modiﬁcation.
A particularly interesting candidate in this respect is the
protein kinase Src, which contains a cysteine switch that is
oxidized in order to achieve full kinase activation. Moreover,
theredox-dependent stimulation ofSrc promotes theligand-
independent transphosphorylation of EGFR and subsequent
activation of PI3 and ERK kinases [175]. In line with this
orderofevents,itispossiblethattheROS-inducedformation
of disulﬁde bonds in Src will stimulate the PI3 and ERK-
dependent eﬀects on nuclear transport factors as they are
discussed here.
The same reasoning applies to several phosphatases
[174], including PTEN and low molecular weight pro-
tein tyrosine phosphatase (LMW-PTP). PTEN is crucial
for the downregulation of PI3 kinase signaling. However,
oxidant-induced thiol modiﬁcation of PTEN inactivates the
phosphatase, and thereby promotes signaling through the
PI3 kinase → Akt module [174]. With respect to nuclear
transport, ROS-induced PTEN inactivation would increase
the impact of PI3 kinase on traﬃcking. In a similar fashion,
the redox-dependent inactivation of LMW-PTP leads to
sustained ERK activation [176]. This could elevate the ERK-
dependent phosphorylation of soluble transport factors and
nucleoporins, thus altering their function.12 Journal of Signal Transduction
Aside from phosphorylation, O-GlcNAc glycosylation of
nucleoporins is induced by oxidative stress. The oxidant-
dependent increase in O-GlcNAc modiﬁcation is possibly
achieved by the complex regulation of O-GlcNAc transferase
and β-N-acetylglucosaminidase. At present, these events are
not fully understood [177].
Taken together, we propose that changes in the cellular
redox homeostasis impact nucleocytoplasmic traﬃcking by
two general mechanisms that are likely to operate in parallel.
First, ROS or ROS-generated compounds directly modify
redox-sensitive transport factors, this can alter their func-
tion. Second, the impact of ROS on redox-sensitive signaling
proteins will ultimately modulate the posttranslational mod-
iﬁcation and activity of nuclear transport components.
2.8. Antioxidant Defenses Occur in a Compartmentalized
Fashion. In addition to the compartmentalized activation
and action of kinases and phosphatases, components of the
antioxidant defense apparatus are also unequally distributed
within the cell [63, 178]. This is illustrated by catalase,
an enzyme concentrated in peroxisomes, and the diﬀerent
forms of superoxide dismutase (SOD) [64, 65, 179, 180].
While manganese-containing SOD (MnSOD) is in the
mitochondrial matrix, copper- and zinc-containing SOD
(Cu,ZnSOD) can be found preferentially in the cytoplasm
and extracellular SOD (EC-SOD) on the cell surface. More-
over, the unequal distribution of GSH and enzymes involved
in GSH metabolism will also contribute to subcellular
diﬀerences in the response to ROS [59, 181–183]. Aside
from these enzymes and antioxidants, the localized action of
chaperones, critical factors for the repair of stress-induced
damage, is well established [115, 184–186]. Since chaperone
function is essential for proper signaling and also required
for nuclear transport, the nucleocytoplasmic localization
and function of heat shock proteins and other chaperones
will have signiﬁcant impact when cells experience ROS
imbalances.
We propose that the unequal distribution of antioxidant
defense and repair components will impact both cargos and
transport factors in a compartment-speciﬁc fashion. Accord-
ingly, the prevention and repair of oxidant-induced damage
will be diﬀerent in the nucleus and cytoplasm. Depending
on its subcellular location, this could have diﬀerential eﬀects
on the movement and function of a shuttling protein. For
example, nuclear cargos that encounter higher levels of ROS
in the cytoplasm could be immobilized in this compartment.
T h es a m em o d e lc a nb ea p p l i e dt on u c l e a rt r a n s p o r tf a c t o r s .
Thus, nucleoporins on the nuclear and cytoplasmic side
of the NPC could be exposed to diﬀerent levels of ROS
and repair. Since nuclear and cytoplasmic nucleoporins
participate in diﬀerent steps of traﬃcking, damage on either
side of the nuclear pore could have unique consequences for
nuclear transport.
3. Conclusions
The impact of ROS on human health is well established,
and links between oxidative stress, nuclear transport, and
disease have been deﬁned. For instance, oxidative stress
plays a pivotal role in the hyperglycemia-induced damage
of multiple tissues and organs [47, 49, 51–53, 55, 187].
GAPDH nucleocytoplasmic shuttling not only participates
in these processes, but has also been connected to cancer
and neurodegenerative disorders, such as ALS, Alzheimer,
or Parkinson disease [88]. Hence, it is conceivable that
the oxidant-induced relocation of GAPDH is common to
diabetes, cancer, and some forms of neurodegeneration. This
shared feature can be extended to the stress-induced nuclear
traﬃcking of the transcriptional regulators NF-κBa n dN r f 2
and may include other diseases, such as Friedreich ataxia
[56, 188, 189].
The examples highlight how the compartment-speciﬁc
action of signaling molecules, defense and repair reactions
provide sophisticated tools to regulate cell physiology.
Thus, conﬁning these processes to speciﬁc locations will
limit the access to downstream targets and clients. In the
context of this review, the nucleocytoplasmic distribution
of kinases, phosphatases, and other factors involved in
posttranslational modiﬁcation or folding can be expected
to directly aﬀect the communication between cytoplasmic
and nuclear compartments. This is emphasized by the
fact that many of the nuclear transport components and
their cargos are modiﬁed in an ROS-dependent fashion by
phosphorylation, O-GlcNAc glycosylation, acetylation, or
sumoylation.
Our current understanding of ROS, signaling, and
nucleocytoplasmic transport supports the notion that these
processes are intricately connected. Although many of
the details are still to be discovered, the ﬁndings from
diﬀerent ﬁelds can be merged into a simpliﬁed model.
Here, we propose that crosstalk and feedback between
diﬀerent components of this signaling circuit will determine
how cells respond to oxidative stress (Figure 5). In one
scenario, the activation of signaling pathways promotes
the posttranslational modiﬁcation of nuclear transport fac-
tors. This triggers the redistribution of transport factors
and alters the movement of cargo across the nuclear
envelope. Alternatively, oxidant-induced damage to the
transport apparatus could modulate the nucleocytoplasmic
localization of kinases or phosphatases, thereby changing
the spatiotemporal pattern of signaling. We believe that
the two scenarios will take place side by side, aﬀecting
diﬀerent signaling modules and targets in the nucleus and
cytoplasm.Bothscenariosarefurthershapedbythelocalized
action of chaperones, which impact both signaling and
nuclear transport. The input from signaling, traﬃcking, and
repair will culminate in the decision on cell survival or
death.
As outlined in this review, the dynamic organization
of signaling cascades and the nuclear transport apparatus
are ideal to respond to internal and external cues. In this
context, nucleocytoplasmic traﬃcking provides the switch
to direct events to the nucleus or cytoplasm. The inter-
dependence of signaling and transport pathways provides
the ﬂexibility to adjust to a wide variety of changes in cell
physiology.Journal of Signal Transduction 13
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Figure 5: Simpliﬁed model for the crosstalk between signaling
and nuclear transport in response to oxidative stress. Oxidative
stress impinges on signaling molecules and the nuclear transport
apparatus, with chaperones modulating both processes. Diﬀerent
scenarios can explain the communication between nuclear trans-
port and signaling pathways in oxidant-treated cells. In one case,
oxidative stress alters the localization and activity of transport
factors.Thiswillchangethesubcellulardistributionofkeysignaling
molecules, which in turn aﬀects the modiﬁcation of downstream
targets. Alternatively, the signaling pathways activated by oxidative
stresscausethemodiﬁcationandredistributionoftransportfactors.
Both scenarios are likely to take place side-by-side, and the balance
of these events will ultimately determine cell fate.
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